|
1
|
A new tumor-specific variant of GRP78 as target for antibody-based therapy.
|
Lab Invest
|
2008
|
1.42
|
|
2
|
High level expression of functional human IgMs in human PER.C6 cells.
|
MAbs
|
2009
|
1.02
|
|
3
|
The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein.
|
Mol Cancer Ther
|
2007
|
1.01
|
|
4
|
The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.
|
PLoS One
|
2013
|
0.98
|
|
5
|
Expression and glycoengineering of functionally active heteromultimeric IgM in plants.
|
Proc Natl Acad Sci U S A
|
2014
|
0.93
|
|
6
|
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients.
|
Hum Antibodies
|
2002
|
0.89
|
|
7
|
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer.
|
Oncol Rep
|
2005
|
0.83
|
|
8
|
The anti-cancer IgM monoclonal antibody PAT-SM6 binds with high avidity to the unfolded protein response regulator GRP78.
|
PLoS One
|
2012
|
0.81
|
|
9
|
Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.
|
Cancer Res
|
2003
|
0.79
|
|
10
|
PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors.
|
Hum Antibodies
|
2004
|
0.77
|
|
11
|
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15.
|
Cancer Res
|
2010
|
0.76
|
|
12
|
Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
|
PLoS One
|
2013
|
0.76
|
|
13
|
Chromatographic behavior of IgM:DNA complexes.
|
J Chromatogr A
|
2010
|
0.75
|